| Thailand HDV Cohort (NCT05350865) | The HIV Netherlands Australia Thailand Research Collaboration | 2023-01-30 |
| Microneedles for Diagnosis of LTBI (NCT04552015) | The HIV Netherlands Australia Thailand Research Collaboration | 2021-04-08 |
| Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals (NCT03785106) | The HIV Netherlands Australia Thailand Research Collaboration | 2019-08-15 |
| Efficacy, Safety and Pharmacokinetics of DTG with RIF (NCT03731559) | The HIV Netherlands Australia Thailand Research Collaboration | 2019-06-25 |
| Self-Assessment Tuberculin Skin Test (NCT03835832) | The HIV Netherlands Australia Thailand Research Collaboration | 2019-06-04 |
| Switching From Protease Inhibitor/Ritonavir to Generic Single Tablet Regimen of Tenofovir Alafenamide/Emtricitibine/Dolutegravir (NCT03727152) | The HIV Netherlands Australia Thailand Research Collaboration | 2019-05-01 |
| Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV (NCT03037151) | The HIV Netherlands Australia Thailand Research Collaboration | 2018-08-01 |
| Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly (NCT02415985) | The HIV Netherlands Australia Thailand Research Collaboration | 2015-06-01 |
| RH and Adolescents (NCT02713750) | The HIV Netherlands Australia Thailand Research Collaboration | 2013-03-01 |
| Abacavir and Lamivudine PK in Children (NCT01656122) | The HIV Netherlands Australia Thailand Research Collaboration | 2012-07-01 |
| Children With HIV and Asthma (CHIVAS) (NCT01644370) | The HIV Netherlands Australia Thailand Research Collaboration | 2011-09-01 |
| Atazavanir/Ritonavir-based HAART in Children (NCT01656109) | The HIV Netherlands Australia Thailand Research Collaboration | 2011-07-01 |
| Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals (NCT03042754) | The HIV Netherlands Australia Thailand Research Collaboration | 2011-06-06 |
| Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA) (NCT01159223) | The HIV Netherlands Australia Thailand Research Collaboration | 2011-05-01 |
| Pediatric Study for Appropriate Dose of Ritonavir Boosted Lopinavir in Thai HIV-infected Children (PEARL) (NCT01307124) | The HIV Netherlands Australia Thailand Research Collaboration | 2011-03-01 |
| Meaning of Life in HIV-infected Youths (NCT01644383) | The HIV Netherlands Australia Thailand Research Collaboration | 2011-02-01 |
| Second-line Therapy (NCT01788891) | The HIV Netherlands Australia Thailand Research Collaboration | 2011-01-01 |
| TDF Long Term Study (NCT01815255) | The HIV Netherlands Australia Thailand Research Collaboration | 2010-12-01 |
| HPV in Adolescents (NCT01788852) | The HIV Netherlands Australia Thailand Research Collaboration | 2010-12-01 |
| Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy (NCT01138202) | The HIV Netherlands Australia Thailand Research Collaboration | 2010-11-01 |
| A Sub-study of PREDICT Neurodevelopment Protocol (NCT02406768) | The HIV Netherlands Australia Thailand Research Collaboration | 2010-10-01 |
| Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children (NCT01225406) | The HIV Netherlands Australia Thailand Research Collaboration | 2010-08-01 |
| Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz (NCT01160120) | The HIV Netherlands Australia Thailand Research Collaboration | 2010-06-01 |
| PK TDF in Thai HIV-infected Children (NCT02404259) | The HIV Netherlands Australia Thailand Research Collaboration | 2010-06-01 |
| Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children (NCT01139905) | The HIV Netherlands Australia Thailand Research Collaboration | 2010-04-01 |
| Pneumococcal Conjugate Vaccine (PCV) in HIV- Infected Children (NCT01135082) | The HIV Netherlands Australia Thailand Research Collaboration | 2010-04-01 |
| Pharmacokinetics of Low Dose Raltegravir (NCT01159132) | The HIV Netherlands Australia Thailand Research Collaboration | 2010-04-01 |
| Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation (NCT01138241) | The HIV Netherlands Australia Thailand Research Collaboration | 2010-03-01 |
| Lopinavir (LPV) Dose Reduction (NCT01159275) | The HIV Netherlands Australia Thailand Research Collaboration | 2009-07-01 |
| The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children (NCT01138215) | The HIV Netherlands Australia Thailand Research Collaboration | 2009-06-01 |
| Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV) (NCT01138267) | The HIV Netherlands Australia Thailand Research Collaboration | 2009-05-01 |
| Hepatitis B Vaccination (HBV) in HIV Infected Children (NCT00886964) | The HIV Netherlands Australia Thailand Research Collaboration | 2009-04-01 |
| Progress Pediatric Study (NCT01328288) | The HIV Netherlands Australia Thailand Research Collaboration | 2009-01-01 |
| Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women (NCT00621166) | The HIV Netherlands Australia Thailand Research Collaboration | 2008-06-01 |
| Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens (NCT00627055) | The HIV Netherlands Australia Thailand Research Collaboration | 2008-05-01 |
| Pharmacokinetics of Low Dose Ritonavir (NCT00622206) | The HIV Netherlands Australia Thailand Research Collaboration | 2008-01-01 |
| TDM of Generic Lopinavir/Ritonavir 200/50 mg (NCT00802334) | The HIV Netherlands Australia Thailand Research Collaboration | 2008-01-01 |
| Progress Adult Study (NCT01328275) | The HIV Netherlands Australia Thailand Research Collaboration | 2007-12-01 |
| Lopinavir/Ritonavir Monotherapy in Children (NCT00626301) | The HIV Netherlands Australia Thailand Research Collaboration | 2007-11-01 |
| Efficacy and Safety of Single Versus Double Ritonavir-boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens (NCT00886990) | The HIV Netherlands Australia Thailand Research Collaboration | 2007-10-01 |
| Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy (NCT00511056) | The HIV Netherlands Australia Thailand Research Collaboration | 2007-09-01 |
| A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects (NCT00476424) | The HIV Netherlands Australia Thailand Research Collaboration | 2007-06-01 |
| Dose Reduction of Lopinavir in Children (NCT00887120) | The HIV Netherlands Australia Thailand Research Collaboration | 2007-04-01 |
| Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1 (NCT00476671) | The HIV Netherlands Australia Thailand Research Collaboration | 2007-03-01 |
| Bioequivalence Study of Generic GPO Ritonavir Versus Norvir® (NCT00477126) | The HIV Netherlands Australia Thailand Research Collaboration | 2007-01-01 |
| Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients (NCT00411957) | The HIV Netherlands Australia Thailand Research Collaboration | 2007-01-01 |
| The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin (NCT00411996) | The HIV Netherlands Australia Thailand Research Collaboration | 2006-12-01 |
| A Study to Test the Efficacy of the HBV Vaccine and to Look at the Prevalence of HBV Infection (NCT00476411) | The HIV Netherlands Australia Thailand Research Collaboration | 2006-12-01 |
| Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r (NCT00476502) | The HIV Netherlands Australia Thailand Research Collaboration | 2006-02-01 |
| Genotyping Directed Salvage Therapy in Children Who Have Failed Dual NRTIs (NCT00477308) | The HIV Netherlands Australia Thailand Research Collaboration | 2006-01-01 |
| Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy (NCT00476853) | The HIV Netherlands Australia Thailand Research Collaboration | 2005-10-01 |
| Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection (NCT00476463) | The HIV Netherlands Australia Thailand Research Collaboration | 2005-04-01 |
| HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection (NCT00476723) | The HIV Netherlands Australia Thailand Research Collaboration | 2005-04-01 |
| Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity (NCT00477048) | The HIV Netherlands Australia Thailand Research Collaboration | 2004-05-01 |
| The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients (NCT00400738) | The HIV Netherlands Australia Thailand Research Collaboration | 2004-03-01 |
| A PK and Salvage Study for Children With HIV-infection (NCT00476359) | The HIV Netherlands Australia Thailand Research Collaboration | 2003-10-01 |
| A Prospective Cohort of Children With HIV Infection (NCT00476606) | The HIV Netherlands Australia Thailand Research Collaboration | 2003-03-01 |
| A Long-term Follow-up of the HIV-NAT Cohort (NCT00411983) | The HIV Netherlands Australia Thailand Research Collaboration | 2002-11-01 |
| Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg (NCT00476983) | The HIV Netherlands Australia Thailand Research Collaboration | |
| Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir® (NCT00622141) | The HIV Netherlands Australia Thailand Research Collaboration | |